Literature DB >> 20607118

Management of Hypnotic Discontinuation in Chronic Insomnia.

Lynda Bélanger1, Geneviève Belleville, Charles Morin.   

Abstract

The management of hypnotic discontinuation following regular and prolonged use may be a challenging task for patients and clinicians alike. Current evidence suggests that a stepped-care approach may be a cost-effective approach to assist patients in tapering hypnotics. This approach may involve simple information about the need to discontinue medication, implementation of a supervised and systematic tapering schedule, with or without professional guidance, and cognitive-behavioral therapy. Research evidence shows that this approach appears promising; further research is however necessary to identify treatment and individual characteristics associated with better outcome.

Entities:  

Year:  2009        PMID: 20607118      PMCID: PMC2896266          DOI: 10.1016/j.jsmc.2009.07.011

Source DB:  PubMed          Journal:  Sleep Med Clin        ISSN: 1556-407X


  43 in total

1.  Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.

Authors:  C R Soldatos; D G Dikeos; A Whitehead
Journal:  Int Clin Psychopharmacol       Date:  1999-09       Impact factor: 1.659

Review 2.  Strategies for discontinuing long-term benzodiazepine use: meta-analysis.

Authors:  Richard C Oude Voshaar; Jaap E Couvée; Anton J L M van Balkom; Paul G H Mulder; Frans G Zitman
Journal:  Br J Psychiatry       Date:  2006-09       Impact factor: 9.319

Review 3.  Treating insomnia: Current and investigational pharmacological approaches.

Authors:  Bjarke Ebert; Keith A Wafford; Stephen Deacon
Journal:  Pharmacol Ther       Date:  2006-07-28       Impact factor: 12.310

4.  Why low-dose benzodiazepine-dependent insomniacs can't escape their sleeping pills.

Authors:  D Schneider-Helmert
Journal:  Acta Psychiatr Scand       Date:  1988-12       Impact factor: 6.392

5.  Substituting behavioural treatment for drugs in the treatment of insomnia: an exploratory study.

Authors:  C A Espie; W R Lindsay; D N Brooks
Journal:  J Behav Ther Exp Psychiatry       Date:  1988-03

6.  Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse.

Authors:  Charles M Morin; Lynda Bélanger; Célyne Bastien; Annie Vallières
Journal:  Behav Res Ther       Date:  2005-01

7.  Relaxation to assist sleep medication withdrawal.

Authors:  K L Lichstein; B A Peterson; B W Riedel; M K Means; M T Epperson; R N Aguillard
Journal:  Behav Modif       Date:  1999-07

Review 8.  Pharmacologic management of insomnia.

Authors:  James K Walsh
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

Review 9.  Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis.

Authors:  Yenal Dündar; Susanna Dodd; Judith Strobl; Angela Boland; Rumona Dickson; Tom Walley
Journal:  Hum Psychopharmacol       Date:  2004-07       Impact factor: 1.672

10.  Hypnotics should not be considered for the initial treatment of chronic insomnia. Con.

Authors:  Edward J Stepanski
Journal:  J Clin Sleep Med       Date:  2005-04-15       Impact factor: 4.062

View more
  3 in total

1.  Personality disorder features and insomnia status amongst hypnotic-dependent adults.

Authors:  Megan E Ruiter; Kenneth L Lichstein; Sidney D Nau; James D Geyer
Journal:  Sleep Med       Date:  2012-08-28       Impact factor: 3.492

Review 2.  Insomnia in the Older Adult.

Authors:  Glenna S Brewster; Barbara Riegel; Philip R Gehrman
Journal:  Sleep Med Clin       Date:  2017-11-22

Review 3.  Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.

Authors:  André S Pollmann; Andrea L Murphy; Joel C Bergman; David M Gardner
Journal:  BMC Pharmacol Toxicol       Date:  2015-07-04       Impact factor: 2.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.